CDK4 and neoplasm: It can also ubiquitinate and degrade cyclin-dependent kinase 4 (CDK4) and ribose-5-phosphate isomerase 23A (RPI23A), leading to cell cycle arrest in the G1 phase and thus inhibiting tumor (GBD, 2021 Osteoarthritis Collaborators, 2023).